SLC6A6 and diabetic kidney disease: As shown in Fig. 3, both WT and TauT-deficient diabetic mice developed mesangial expansion 3 months after STZ treatment, a sign of the early stages of diabetic nephropathy; however, it was more prominent in the TauT mutant mice, especially in TauT-/- mice.